MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.bbmt.2006.09.002

Медицинская библиотека · Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2007

Allogeneic bone marrow transplantation from unrelated human T-cell leukemia virus-I-negative donors for adult T-cell leukemia/lymphoma: retrospective analysis of data from the Japan Marrow Donor Program.

Kato Koji, Kanda Yoshinobu, Eto Tetsuya, Muta Tsuyoshi, Gondo Hisashi, Taniguchi Shuichi, Shibuya Tsunefumi, Utsunomiya Atae, Kawase Takakazu, Kato Shunichi, Morishima Yasuo, Kodera Yoshihisa, Harada Mine, Japan Marrow Donor Program

СтатьяМногоцентровое исследованиеПеревод пока не подготовлен

Аннотация

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) from an HLA-matched related donor has been suggested to improve the poor prognosis of adult T-cell leukemia/lymphoma (ATLL). However, the infusion of HTLV-I-infected cells from HTLV-I-positive related donors could lead to the development of donor-derived ATLL under immunosuppressive conditions. Although most ATLL patients lack a suitable HLA-matched related donor and require an HTLV-I-negative unrelated donor, little information is currently available regarding the outcome of unrelated bone marrow transplantation (UBMT) for ATLL. To evaluate the role of UBMT in treating ATLL, we retrospectively analyzed data from 33 patients with ATLL treated by UBMT through the Japan Marrow Donor Program (JMDP). Overall survival (OS), progression-free survival, and cumulative incidence of disease progression and progression-free mortality at 1 year after UBMT were 49.5%, 49.2%, 18.6%, and 32.3%, respectively. Multivariate analysis identified recipient age as an independent prognostic factor for OS (P = .044). Patients age >or=50 years who showed nonremission at transplantation tended to have higher rates of treatment-related mortality. Our observations suggest that UBMT could represent a feasible treatment option for ATLL patients and warrant further investigation based on these risk factors.

Для цитирования: Kato Koji, Kanda Yoshinobu, Eto Tetsuya, Muta Tsuyoshi, Gondo Hisashi, Taniguchi Shuichi, Shibuya Tsunefumi, Utsunomiya Atae, Kawase Takakazu, Kato Shunichi, Morishima Yasuo, Kodera Yoshihisa, Harada Mine, Japan Marrow Donor Program. Allogeneic bone marrow transplantation from unrelated human T-cell leukemia virus-I-negative donors for adult T-cell leukemia/lymphoma: retrospective analysis of data from the Japan Marrow Donor Program.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2007. DOI: 10.1016/j.bbmt.2006.09.002.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.